CustoScan

CustoScan supplies customers across the EU and USA with advanced cell and gene therapy (CGT) products from leading Chinese biotechnology companies, including BioSwan Laboratories and T&L Biotechnology. BioSwan’s anti-CD19 CAR T-cell detection antibody enables highly sensitive flow cytometric detection down to 0.001%, supporting precise monitoring of CAR-T therapies. T&L offers recombinant proteins, cytokines and drug-targeting antigens, alongside cGMP-standard manufacturing capabilities for mammalian cell expression, in vitro reagents and cell therapy development. T&L is ISO 13485 and ISO 9001 certified, holds NK cell production patents, and has several FDA- and DMF-registered products.